Scientists probe hidden pathway to unlock new treatments for Heart-Lung disease
NCT ID NCT07537517
First seen May 02, 2026 · Last updated May 21, 2026 · Updated 4 times
Summary
This study looks at how a specific cell signaling pathway (BMPR2-activin) contributes to pulmonary hypertension in people with heart failure. Researchers will follow 150 patients for one year, using blood tests, heart imaging, and tissue samples to understand the disease better. The goal is to improve diagnosis and find new treatment targets, such as activin inhibitors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hospital GU Gregorio Marañón
RECRUITINGMadrid, Madrid, 28007, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.